Malaria No More UK’s Post

This is big news for the malaria fight 🦟 🚫

View organization page for GSK, graphic

4,151,216 followers

Today marks a critical milestone in helping improve the treatment for malaria. The World Health Organization has granted prequalification to tafenoquine, the first single-dose medicine for the prevention of relapse of Plasmodium vivax for adults (P. vivax) malaria, co-administered with chloroquine for radical cure. This recognition highlights our collective commitment to addressing the specific needs of vulnerable populations at risk of malaria in endemic countries as well as advancing access to treatment options for all. And in a step towards closing the treatment gap and disproportionate burden between adults and children, the WHO has granted prequalification to paediatric tafenoquine. Additionally, the WHOs Guidelines for malaria have been updated to recommend the use of the single-dose medicine to prevent relapsing malaria for the first time, in South America. Together, with our partners Medicines for Malaria Venture we are taking important steps towards a malaria-free future.

Abdoul-Fataou MAIGA

Medical Doctor//Project Manager//Malaria Champion//Burkina Red-Cross Volunteer//Global Health//Passionate about Community Heath and Prevention

1w

Great new!!!

Like
Reply

Love this

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics